For each year, activity records were assembled.
Based on the selection criteria detailed above, two sets of compounds with high- and low-confidence activity data were assembled.
The time period for which the activity records were assembled spanned a maximum of 24 years (for captopril, from 1981 to 2005), with an average of 3.3 years per drug.
Networks of converging gene and enhancer modules were assembled into six and four global patterns of expression and activity across time.
Porous TiO2-NSs were assembled by refluxing the TiO2-H2O colloid and exhibited enhanced photocatalysis activity compared to the nanoparticles.
Compound sets were assembled by applying different data confidence criteria and selecting compounds with activity histories over many years.
Sequences were assembled using PEAR.
Witnesses were assembled and interviewed.
Images were assembled using Photoshop.
Chromatograms were assembled in DNASTAR Lasergene SeqMan Pro v.7.1.0.
Four transcriptomes were assembled.
